Jefferies Raises Core Scientific Price Target to 37 Citing AI Infrastructure Demand Growth Inflation Pressures Broaden Beyond Iran and Oil Shelter and Services Show Renewed Price Increases Q4 Earnings Roundup EID Parry Reports Loss Marksans Pharma and Astra Microwave See Profit Gains AIA Engineering Declines Jim Cramer Expresses Disappointment Over Toll Brothers Outlook Over OneThird of TwoYear Mutual Fund SIPs Report Losses Market Timing and Sector Selection Matter Custard Apple Hardy Plant Fragile Fruit Poses Export Challenge GWAV Q3 2023 Earnings Loss per Share Reported at 175 as Company Focuses on Operational Improvements WFRD Q1 2026 Earnings EPS Surges Past Estimates by 39 Stock Declines Slightly ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains DNLI Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction Verastem Q1 2026 Earnings NarrowerthanExpected Loss Beats Estimates Stock Edges Higher PRTH Q1 2026 Earnings EPS Surpasses Estimates by 277 Despite Modest Share Decline Banzai International BNZI Slips 172 as Stock Tests Key Support Near 381 Tvardi Therapeutics TVRD Holds Steady Near Support Amid LowVolume Trading Columbia Sportswear COLM Rallies 38 as Shares Bounce From Key Support Level LanzaTech Global LNZA Slides 72 as Resistance Holds Firm Key Support in Focus RTX Corporation RTX Gains 137 as Defense Sector Shows Resilience Manufacturing Employment Data Underscore Uneven Impact of TrumpEra Tariffs Cato Institute Analysis Suggests PMCB Q1 2026 Earnings PreRevenue Biotech Reports Negative EPS Stock Rises on Potential Pipeline Progress Pan American Silver PAAS Slips 26 as Silver Prices Weigh Support at 5124 in Focus Fortress Biotech Preferred Shares FBIOP Advance 245 as Support Holds Near 16 Andersons Inc ANDE Edges Higher as Support Holds Resistance Test Potentially Ahead Crown Reserve Acquisition Corp I Rights CRACR Holds Steady at 015 Amid Limited Trading Activity Xenetic Biosciences XBIO Edges Lower Amid Tight Trading Range Huadi International Group HUDI Faces Steep Decline Testing Key Support at 10 Cardiol Therapeutics Inc CRDL Modestly Advances as It Holds Above Key Support Corbus Pharmaceuticals CRBP Slides 14 as Key Support Level Comes into Focus